Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes

August 2008

Does intensive blood-glucose lowering reduce the risk of cardiovascular disease in patients with type 2 diabetes?

We know that lowering A1c decreases the risk of microvascular disease such as retinopathy and nephropathy.

So many experts hoped it would also improve MACROvascular outcomes such as heart attacks and strokes.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Already a subscriber? Log in

Volume pricing available. Get a quote